Spire Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.88K Hold
13
﹤0.01% 1750
2026
Q1
$6.24K Sell
13
-9,455
-100% -$4.84M ﹤0.01% 1779
2025
Q4
$5.32M Buy
9,468
+9,467
+946,700% +$5.37M 0.18% 115
2025
Q3
$514 Buy
+1
New +$437 ﹤0.01% 2351
2025
Q2
Sell
-37
Closed -$11.3K 2494
2025
Q1
$11.3K Buy
37
+34
+1,133% +$11.4K ﹤0.01% 1802
2024
Q4
$997 Sell
3
-1
-25% -$339 ﹤0.01% 2372
2024
Q3
$1.33K Sell
4
-9
-69% -$3.42K ﹤0.01% 2061
2024
Q2
$5.35K Sell
13
-1
-7% -$396 ﹤0.01% 1813
2024
Q1
$5.66K Hold
14
﹤0.01% 1899
2023
Q4
$4.14K Buy
14
+3
+27% +$810 ﹤0.01% 2010
2023
Q3
$2.66K Hold
11
﹤0.01% 2072
2023
Q2
$2.64K Sell
11
-100
-90% -$20.8K ﹤0.01% 2145
2023
Q1
$20.9K Buy
111
+98
+754% +$20.3K ﹤0.01% 1602
2022
Q4
$3K Buy
13
+2
+18% +$400 ﹤0.01% 1971
2022
Q3
$2K Hold
11
﹤0.01% 1967
2022
Q2
$2K Buy
+11
New +$1.59K ﹤0.01% 2373

Other funds holding MEDP

Spire Wealth Management's MEDP Position: Q2 2026 in Review

Spire Wealth Management held its Medpace (MEDP) position steady in Q2 2026 at 13 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Spire Wealth Management first reported a position in MEDP in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.32M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Spire Wealth Management held 13 shares of Medpace worth $6.88K as of Q2 2026.
  • Spire Wealth Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1750 holding.
  • Spire Wealth Management first reported a position in Medpace in Q2 2022 and has held it in 16 quarters since.
  • Spire Wealth Management's Medpace position peaked at $5.32M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.